Biotech Investing Cizzle Brands Strengthens U.S. Footprint of CWENCH Hydration With Availability at United Supermarkets in Texas
Biotech Investing Cizzle Brands Announces that All 134 Metro Locations in Ontario Will be Offering CWENCH Hydration Ready-to-Drink Beverages
Biotech Investing UPLIZNA® IS NOW THE FIRST AND ONLY FDA-APPROVED TREATMENT FOR IGG4-RELATED DISEASE
Biotech Investing Cizzle Brands Adds to its Presence in Ontario with Placements of CWENCH Hydration in Healthy Planet and Farm Boy
Biotech Investing Cizzle Brands Begins Distributing CWENCH Hydration to Metro Grocery Stores in Quebec
Biotech Investing Cizzle Brands Corporation Reports $5.64 Million in Net Sales in the First Half of its 2025 Fiscal Year
Biotech Investing UPLIZNA® SIGNIFICANTLY IMPROVES GENERALIZED MYASTHENIA GRAVIS SYMPTOMS IN ACETYLCHOLINE RECEPTOR AUTOANTIBODY-POSITIVE PATIENTS OVER 52 WEEKS
